secwatch / observer
8-K filed January 27, 2022, 6:59 PM ET ticker HCA CIK 0000860730
earnings confidence high sentiment positive materiality 0.85

HCA Q4 net income $1.81B ($5.75 EPS); guides 2022 rev $60-62B; $8B buyback

HCA Healthcare, Inc.

2021-FY EPS reported $21.16 revenue$58,752,000,000

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Andrea B. Smith

Director
HCA · HCA Healthcare, Inc.
Effective
2022-01-26
Filed
January 27, 2022, 6:59 PM ET
On January 24, 2022, the Company’s Board of Directors (the “Board”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Andrea B. Smith to the Company’s Board effective January 26, 2022, increasing the number of directors on the Board from 10 to 11.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrea B. Smith was appointed as director at HCA Healthcare, Inc..

Action
appointed
Exact text from the filing
On January 24, 2022, the Company’s Board of Directors (the “Board”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Andrea B. Smith to the Company’s Board effective January 26, 2022, increasing the number of directors on the Board from 10 to 11.
View on SEC.gov

HCA Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-019075
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.